SCHEMBL17451693

SCHEMBL17451693

c1ccc(-c2cc(-c3ccc(-n4c5ccccc5c5c6c7ccccc7oc6c6ccccc6c54)cc3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.36
ALDH1A1 P00352 8/20 0.36
KMT2A Q03164 6/20 0.36
MEN1 O00255 5/20 0.36
HPGD P15428 4/20 0.36
NTSR1 P30989 1/20 0.36
TSHR P16473 5/20 0.35
KDM4E B2RXH2 5/20 0.33
LMNA P02545 5/20 0.33
POLB P06746 3/20 0.33
HSD17B10 Q99714 3/20 0.33
MAPK1 P28482 2/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
GLA P06280 1/20 0.33
BRCA1 P38398 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
USP2 O75604 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17451717 1.00 MAPT (0.36) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL17451683 0.93 MAPT (0.38) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL17405724 0.93 MAPT (0.37) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL17405720 0.93 MAPT (0.37) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL17405637 0.93 MAPT (0.37) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL17405625 0.93 MAPT (0.37) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL17405912 0.92 MAPT (0.36) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL17228943 0.92 MAPT (0.36) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL17406080 0.92 ALDH1A1 (0.36) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL17405919 0.92 MAPT (0.36) MAPTALDH1A1KMT2AMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9799835-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2017-10-24 US disclosed
US-9799835-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2017-10-24 US disclosed
US-20160020410-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2016-01-21 US disclosed
US-20160020410-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2016-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160020410-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF OR51E2, NFE2L2, ORAI2 MAPT 1366/4885ALDH1A1 1349/4885KMT2A 606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.